Enhanced Motor Recovery Using Serotonergic Agents in Stroke
Condition(s):Patients With Chronic StrokeLast Updated:December 28, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Patients With Chronic StrokeLast Updated:December 28, 2016Completed
Condition(s):Basic ScienceLast Updated:November 18, 2023Recruiting
Condition(s):HealthyLast Updated:November 29, 2023Completed
Condition(s):Schizophrenia; Psychotic Disorders; Mood Disorders; Schizophrenia Spectrum; Mental Disorders; Antipsychotic Agents; Tranquilizing Agents; Central Nervous System Depressants; Physiological Effects of Drugs; Psychotropic Drugs; Neurotransmitter Agents; Molecular Mechanisms of Pharmacological ActionLast Updated:April 25, 2023Completed
Condition(s):Schizophrenia; Psychotic Disorders; Mood Disorders; Schizophrenia Spectrum and Other Psychotic Disorders; Mental Disorders; Antipsychotic Agents; Tranquilizing Agents; Central Nervous System Depression; Physiological Effects of Drugs; Psychotropic Drugs; Neurotransmitter Agents; Molecular Mechanisms of Pharmacological ActionLast Updated:March 19, 2024Completed
Condition(s):Autism Spectrum DisorderLast Updated:February 6, 2024Not yet recruiting
Condition(s):Social Anxiety DisorderLast Updated:December 22, 2023Active, not recruiting
Condition(s):DepressionLast Updated:October 6, 2020Completed
Condition(s):MigraineLast Updated:July 20, 2016Unknown status
Condition(s):Carcinoid Tumors; Neuroendocrine TumorsLast Updated:April 13, 2018Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.